DKDenis Viktorovich Krivorotov

Denis Viktorovich Krivorotov

*This is an algorithmically generated author record based on publicly available information.

Denis Viktorovich Krivorotov has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Scientific legacy of Nikolai Vasilyevich Lazarev: to the 130th anniversary of the birth of an outstanding toxicologist and pharmacologist

    by Tatyana A. Fedorova, Valeria O. Mineeva, Denis V. Krivorotov, Andrei S. Radilov, Татьяна Александровна Федорова, Валерия Олеговна Минеева, Денис Викторович Криворотов, Андрей Станиславович Радилов

    Received: April 27, 2026 / Revised: May 22, 2026 / Accepted: June 1, 2026 / Published: June 30, 2026

  • Open Access

    Honey-based hydrogel: A promising new-generation antimicrobial coating?

    by E. N. Karpina, E. V. Fedotova, F. F. Zaripova, D. V. Krivorotov, A. S. Radilov

    Introduction. The development of hydrogel coatings is a promising research direction in burn injury therapy. Honey-based hydrogels possess unique physicochemical characteristics due to being transparent, capable of effectively absorbing exudate, and exhibiting low pH values. All these properties make them ideal candidates for application not only in cosmetology but also in medicine for the transdermal delivery of various medicinal substances. Objective. Synthesis of honey-based hydrogels and comparative analysis of their physicochemical characteristics and antibacterial activity. Materials and methods. Hydrogels were synthesized based on chitosan and сarbopol with addition of 25, 50, and 75 wt % of white honey. The following parameters were investigated: viscosity (using a Brookfield rotational viscometer); spreadability (by a compression method); degree of sample swelling; stability (by centrifugation); honey release from the sample (using an ERWEKA DT-820 tester); analysis of the quantitative honey content in the buffer (by spectrophotometry). The study of in vitro antibacterial properties was conducted using Candida  albicans ATCC 64550 (a yeast-like fungus), Staphylococcus aureus ATCC 25913 (a gram-positive bacterium), Escherichia coli ATCC 25922 (a gram-negative bacterium), Acinetobacter baumannii 897 (a gram-negative bacterium), Enterobacter cloacae ATCC 13047 (a gram-negative bacterium), Klebsiella pneumoniae ATCC 19606 (a gram-negative bacterium). Statistical data processing was performed using the DeltaX 3.0 software. Results. In terms of viscosity, the hydrogel based on 1% Carbopol 940 with a honey concentration of 25 wt % outperformed other gels. The samples based on 1% Carbopol ETD 2020 with a honey concentration of 50 wt % exhibited the lowest spreadability. The highest sorption capacity 1 h and 3 h after the onset of testing was demonstrated by the sample based on 3.5% low-viscosity chitosan with a honey concentration of 25 wt %. The highest honey release was shown by the sample based on 10% low-viscosity chitosan with a honey concentration of 50 wt %. Conclusions. The conducted study of physicochemical and antibacterial properties render chitosan-based hydrogels promising for further investigation. Hydrogel samples with a 75% honey concentration failed the stability test, which make them unsuitable for use as a therapeutic delivery system. Based on the results obtained, a mixed hydrogel based on Carbopol 940 and 3.5% low-viscosity chitosan is recommended for further research.

  • Evaluation of acute toxicity and pharmacokinetics of a natural phaeosphaeride A derivative in laboratory rodents

    by V. V. Abzianidze, N. V. Skvortsov, G. V. Karakashev, P. P. Beltyukov, D. S. Suponina, V. O. Musatova, A. S. Bogachenkov, D. V. Krivorotov

    Introduction. The determination of metabolism and pharmacokinetics is an essential requirement in the development of any drug. Phaeosphaeride A (PPA) is an anticancer agent belonging to the group of natural compounds with antitumor properties, which was first isolated from the endophytic fungus FA39 by Harvard scientists (Claudy et al.) in 2006. In this study, we investigate compound AV6, which is a derivative of natural phaeosphaeride A. Objective. To study the acute toxicity and pharmacokinetic characteristics of the semi-synthetic substance AV6 obtained based on phaeosphaeride A, a natural phytotoxin with antitumor properties, following a single intragastric administration of AV6 in laboratory rodents. Materials and methods . The acute toxicity of AV6 was studied using 30 male Balb/c mice, which were divided into five groups of six animals each. The control group received a single intragastric administration of a solvent (oil-alcohol emulsion, 300 µL volume), while four experimental groups received AV6 at doses of 5, 50, 300, and 2000 mg/kg bw. Body weight dynamics were evaluated, and organ mass coefficients were calculated. The pharmacokinetic study was performed following a single intragastric administration of AV6 at a dose of 25 mg/kg bw to outbred male Wistar rats. The AV6 dose for the pharmacokinetic study was determined based on acute toxicity data, accounting for the interspecies conversion factor. Quantitative determination of AV6 in blood plasma and urine was performed using the MS/MS method. Statistical analysis was conducted using GraphPad Prism 5 software. Results. According to the acute toxicity data following intragastric administration, the AV6 phaeosphaeride A derivative can be classified as hazard class 3 (animal mortality was observed exclusively in the 2000 mg/kg bw group). Visual examination of internal organs revealed no apparent macroscopic signs of pathology. No statistically significant changes in the mass coefficients of internal organs were detected in experimental animals compared to controls. A quantitative determination procedure for AV6 was developed based on HPLC–MS/MS analysis. Metabolites formed in rats in vivo were identified. A comparison of rat blood plasma chromatograms 1 h and 10 h after intragastric AV6 administration showed that, after 1 h, the AV6 peak intensity was 20 times higher than the M2 peak. However, after 10 h, the AV6 peak intensity decreased, while the metabolite M2 peak intensity increased. Conclusion. Compound AV6 is classified as a moderately hazardous substance. Data on the structure of AV6 metabolites (a derivative of natural phaeosphaeride A) obtained during pharmacokinetic studies in rats indicate a relatively low metabolic rate of the compound. This is primarily due to chemical transformations at the nitrogen atom of the lactam ring, resulting in metabolites that may be excreted in urine. The most probable mechanisms of these transformations are oxidative deacylation followed by hydrolysis. The completed preclinical study evaluating the acute toxicity, metabolism, and pharmacokinetics of AV6 represents a crucial step in translating previous findings on the antitumor potential of this derivative of natural phaeosphaeride A and advancing in vivo research.

  • Open Access

    Soy lecithin-based liposomes for lymphatic delivery of biologically active substances

    by E. V. Fedotova, N. V. Skvortsov, I. E. Perevoznikov, N. Yu. Rogovskaya, A. A. Bardin, P. P. Beltyukov, V. N. Babakov, D. V. Krivorotov, A. S. Radilov, Н. Ю. Роговская

    Липосомы из соевого лецитина для лимфатической доставки биологически активных веществ

  • Open Access

    Physical and chemical criteria for hazard assessment of CNS-active xenobiotics

    by D. V. Krivorotov, A. I. Nikolaev, A. S. Radilov, В. Р. Рембовский, V. A. Kuznetsov

    Introduction. Forensic medical examinations frequently encounter poorly understood, potentially hazardous psychoactive substances. At the same time, information on the biological activity of such substances may be either fragmentary and contradictory or absent altogether. Therefore, the development of approaches to predicting the health hazard of xenobiotics is an urgent task of emergency medicine.Objective. To study the relationship between physicochemical properties and the hazard rate of one class of CNS-active substances using the methods of mathematical analysis followed by scientific substantiation of criteria for preliminary hazard assessment of narcotic drugs.Маterials and methods. The study models included the known structures of narcotic analgesics, divided into three groups according to their potential hazard rate. The physicochemical properties of such substances, i.e., molecular weight, polarity, polar surface area, distribution coefficients, and basic dissociation constants were considered as potential hazard factors. Linear discriminant analysis was used to identify the relationship between the physicochemical properties of psychoactive substances and their hazard potential.Results. The considered example of one class of CNS-active substances confirms the relationship between their hazard rate and the physicochemical properties affecting their redistribution from the central bloodstream to the central nervous system. Physicochemical criteria for predicting the hazard rate of psychoactive substances are proposed. These criteria serve as classification functions that distinguish groups of model substances.Conclusions. The physicochemical properties of psychoactive substances and the strength of their binding to target receptors equally determine the characteristics of their toxic effect. The formulated classification functions, calculated based on the physicochemical properties of substances, can be used for a preliminary hazard assessment of xenobiotics during their detection in biological samples.


  • Open Access

    Prospects for the use of intranasal nanoscale polymer delivery systems for drugs and antidotes in extreme medicine

    by E. V. Fedotova, D. V. Krivorotov, A. S. Radilov

    Introduction. The development of improved formulations of antidotes and remedies, which can be used not only by qualified medical personnel, but also in self- and mutual assistance, is an urgent task for extreme medicine.Objective. Evaluation of the possibility of using nanoscale polymer delivery systems for medicines and antidotes intended for intranasal administration (into the nasal cavity) in extreme medicine.Discussion. The main submicron-sized polymer carriers which are promising as the basis for the creation of an intranasal form of antidotes are identified. The bioavailability of the substance delivered is dependent on the physico-chemical properties of the carrier, the conditions for its production, as well as physiological and anatomical factors. Data is presented regarding possible ways of correcting these factors in order to increase bioavailability. Examples of the use of polymer nanocarriers in the treatment of poisoning with heavy metals and rocket fuel components, as well as lesions caused by radioactive substances, are presented. It is shown that carriers (dendrimers, cyclodextrins) can act as antidotes in certain cases. The study presents a list of antidotes approved for use within the territory of the Russian Federation, for which the development of intranasal forms is possible, taking their physico-chemical and pharmacokinetic properties into account.Conclusions. Following a review of literature sources, the most promising submicron-sized polymer carriers for the intensification of intranasal delivery of drugs and antidotes are herein proposed: dendrimers, liposomes, nanocapsules, nanoparticles, and cyclodextrins. Using the list of antidotes approved for use in the Russian Federation as an example, promising drugs that can be potentially developed on the basis of these carriers are proposed.

  • New biomarkers for 1,1-dimethylhydrazine

    by Anton Igorevich Ukolov, Denis Sergeevich Laptev, Evgeny Yurievich Karmanov, Georgy Vasilyevich Karakashev, Denis Viktorovich Krivorotov, A. S. Bogachenkov, Olga Valeryevna Nechaikina, Dmitry Vladimirovich Bobkov, Sergey Gervasievich Petunov

    Introduction. Despite the large-scale use of asymmetric dimethylhydrazine (UDMH) in the domestic rocket and space industry, its biomarkers of exposure in blood plasma and urine, as well as biomarkers of cardiotoxic effects, have not yet been described. Material and methods. The study of blood and urine samples of rats after a single injection of 10 mg/kg UDMH (1/16 LD50) was carried out by HPLC-MS. The determination of the non-metabolized form of UDMH was also carried out using the method of gas chromatography with mass-selective detection with preliminary derivatization with 4-pyridinecarboxyaldehyde. The cardiotoxic effect of UDMH was assessed on a model of an isolated rat heart with subchronic intragastric administration for 28 days at doses of 0,02; 0,2; 2,0 mg/kg. Results. It has been established that the main metabolites of UDMH are dimethylhydrazones of pyridoxal (vitamin B6) and pyruvic acid (pyruvate). The possibility of determining the non-metabolized form of UDMH in blood and urine by HPLC-MS was shown, concentrations reach 10-60 ng/ml of blood plasma and 200-2000 ng/ml. The use of UDMH leads to an increase in the mass coefficient of the heart at a dose of 2,0 mg/kg. In ex vivo experiments on the rat heart, the cardiotoxic effect of UDMH was shown at subchronic use at a dose of 0,2 mg/kg and above, expressed in significant dilatation of the coronary bloodstream and left ventricle, the development of pronounced negative inotropic and chronotropic effects, and a decrease in the maximum rate of contraction and relaxation of the left ventricle. ventricle, reflecting the inhibition of myocardial energy metabolism. Limitations of the study. In the work, biomarkers were detected after a single intragastric injection of NDMG, the toxicokinetic characteristics of biomarkers and their retrospectivity were not evaluated. Conclusion. The main metabolites of UDMH with intravenous administration of 1/16 DL50 are dimethylhydrazones of pyridoxal (vitamin B6) and pyruvic acid (pyruvate). With subchronic administration, UDMH has cardiotoxicity at a dose of 0,02 mg/kg and above.


  • Experimental comparing of lipophilicity of opioid antagonists

    by Denis Viktorovich Krivorotov, Dmitrij Mikhajlovich Kochura, Sergej Anatolevich Dulov, Andrej Stanislavovich Radilov

    Introduction. The high lipophilicity of synthetic opioids determines their abnormally high toxicity in comparison with natural opiates. The need to develop medical treatment of poisoning with such substances validates the task to study experimentally the logP partition coefficients of narcotic analgesics and their antagonists in standardized conditions close to the conditions of a living organism. Material and methods. The lipophilicity of pharmacological agents was determined in accordance with the principles of GOST 32474-2013. “Methods of testing chemical products that pose a threat to the environment. The determination of the n-octanol/water partition coefficient by high-performance liquid chromatography”, using the selected calibration dependence of the lipophilicity values on the logarithm of the retention factor of the substances studied. Results. The HPLC method has been proposed to determine the logP value of opioid antagonists using selected reference pharmacological agents. The method has revealed a linear dependence of the logP of CNS-active pharmacological agents on the logarithm of their retention factor in the chromatographic column, which allowed to determine the logP value of a number of opioid receptor antagonists and a model representative of synthetic opioids in one experiment. Limitations. The calibration dependence of the lipophilicity value on the logarithm of the retention factor of the studied substances has been obtained using reference logP values of a limited number of reference substances. Conclusion. When conducting pharmacological studies, using the HPLC method for the definition of logP provides high reproducibility of measurement conditions close to the conditions of a living organism and allows to compare the results obtained. Thus, the correlation of the logP values, found by the HPLC method, has showed a ten times lower lipophilicity of naloxone relative to fentanyl. The largest value of logP, among the studied opioid receptor antagonists used in clinical practice, was found for nalmefene.


  • PAMAM dendrimers and prospects of their application in medicine

    by Ev Popova, Dv Krivorotov, Rv Gamazkov, As Radilov

    Development of drug delivery systems based on branched biocompatible polymers is one of the most promising areas of modern nanopharmaceutics. Researchers have been exploring this area several decades now, and the results of their efforts quickly find their way into production. Dendrimers, a new class of universal synthetic polymers with a highly functional surface, have a number of unique properties: constant size, high degree of branching, multivalence, solubility in water, definite molecular weight, internal cavities. With the release of VivaSol gel, the first dendrimer-based commercialized product, the "model range" of dendrimer carriers has grown significantly. Poly(amide-amine) (PAMAM) dendrimers, which consist of an alkyldiamine core and tertiary amine branches, are believed to be among the most promising compounds that can be used in the development of the new generation drugs. However, they were kept out of the list of clinically acceptable compounds for a long time because of their toxicity, unclear behavior in living systems and pharmacokinetic profile, as well the difficulties associated with establishing a therapeutic dose. This review presents basic information about PAMAM dendrimers and attempts to assess the prospects of their application in treatment of various diseases, including COVID-19.